Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT)

被引:1
|
作者
Yoshimasu, T [1 ]
Hiroi, A [1 ]
Uede, K [1 ]
Furukawa, F [1 ]
机构
[1] Wakayama Med Univ, Dept Dermatol, Wakayama 6410012, Japan
关键词
discoid lupus erythematosus; drug-induced lupus erythematosus; UFT; photosensitivity;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A mixture of uracil and tegafur (UFT) is a common antineoplastic agent in Japan. We report a 64-year-old Japanese woman with discoid lupus erythematosus (DLE)-like lesions which were induced by UFT. After surgery to treat lung cancer, UFT (300 mg/day) was administered and she developed round erythema on her right cheek. A skin biopsy specimen taken from the right cheek site revealed atrophy of the epidermis, a slight liquefaction of the basal cell layer, and patchy lymphocytic infiltration in the perivascular and perifollicular regions. A test for antinuclear antibody was weakly positive (80 fold), and rheumatoid factor was slightly elevated (7.6 IU/ml), After discontinuation of UFT, the erythema completely regressed within 2 months. We reviewed 17 cases of DLE-like lesions induced by fluorouracil agents and summarized the common features.
引用
收藏
页码:54 / 57
页数:4
相关论文
共 50 条
  • [21] Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule
    Pazdur, R
    Lassere, Y
    DiazCanton, E
    Bready, B
    Ho, DH
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (02) : 123 - 128
  • [22] Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule
    Pazdur, R
    Lassere, Y
    Diaz-Canton, E
    Ho, DH
    CANCER INVESTIGATION, 1998, 16 (03) : 145 - 151
  • [23] Uracil-tegafur (UFT) based radiochemotherapy in adjuvant treatment of resected high risk gastric cancer.
    Gemici, C
    Demir, O
    Salepci, T
    Gumus, M
    Mayadagli, A
    Seseogullari, OO
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
  • [24] DS-DNA-ANTIBODIES IN DISCOID LUPUS-ERYTHEMATOSUS (DLE)
    BANYAI, A
    NAGY, E
    SZEGEDI, G
    MESZAROS, C
    ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1982, 57 (21): : 1583 - 1586
  • [25] Rapid clearance of cutaneous lesions with anifrolumab in SLE (systemic lupus erythematosus) and DLE (discoid lupus erythematosus)
    Parriel, E.
    Bulai-Livideanu, C.
    Severino-Freire, M.
    Delpuech, A.
    Faguer, S.
    Belliere, J.
    Huart, A.
    Paul, C.
    JEADV CLINICAL PRACTICE, 2025, 4 (01): : 207 - 215
  • [26] Phase I trial of Uracil-Tegafur (UFT) plus oral leucovorin: 14-day schedule
    Richard Pazdur
    Yvonne Lassere
    Enrique Diaz-Canton
    Beth Bready
    Dah H. Ho
    Investigational New Drugs, 1997, 15 : 123 - 128
  • [27] SOFT-TISSUE CALCIFICATIONS IN DISSEMINATED DISCOID LUPUS-ERYTHEMATOSUS (DLE)
    JOHANSSON, E
    KANERVA, L
    NIEMA, KM
    VALIMAKI, M
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (04) : 303 - 303
  • [28] Discoid lupus erythematosus-like eruption induced by infliximab
    Stratigos, AJ
    Antoniou, C
    Stamathioudaki, S
    Avgerinou, G
    Tsega, A
    Katsambas, AD
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (02) : 150 - 153
  • [29] INCREASED NUMBERS OF B-LYMPHOCYTES IN DISCOID LUPUS-ERYTHEMATOSUS (DLE)
    GILLIAM, JN
    HURD, ER
    CLINICAL RESEARCH, 1976, 24 (03): : A263 - A263
  • [30] Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial
    Fujii, Masashi
    Takayama, Tadatoshi
    Kochi, Mitsugu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (12) : 1319 - 1323